KR100668570B1 - 복재신경 포착에 의한 무릎 관절 통증 치료를 위한,보툴리눔 독소를 포함하는 제약 조성물 - Google Patents
복재신경 포착에 의한 무릎 관절 통증 치료를 위한,보툴리눔 독소를 포함하는 제약 조성물 Download PDFInfo
- Publication number
- KR100668570B1 KR100668570B1 KR1020040048889A KR20040048889A KR100668570B1 KR 100668570 B1 KR100668570 B1 KR 100668570B1 KR 1020040048889 A KR1020040048889 A KR 1020040048889A KR 20040048889 A KR20040048889 A KR 20040048889A KR 100668570 B1 KR100668570 B1 KR 100668570B1
- Authority
- KR
- South Korea
- Prior art keywords
- botulinum toxin
- pain
- pharmaceutical composition
- knee
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Abstract
Description
대조군 | 보툴리늄 독소 타입 A 투여군 | p 값 | |
기준선 | 8.10 ±2.16 | 7.35 ±2.44 | NS |
1주 후 | 6.75 ±2.64 | 5.83 ±2.45 | NS |
3주 후 | 6.03 ±2.35 | 4.59 ±2.69 | < 0.05 |
대조군 | 보툴리늄 독소 타입 A 투여군 | p 값 | |
기준선 | 17.1 ±6.50 | 13.4 ±6.54 | NS |
1주 후 | 16.9 ±6.30 | 12.1 ±5.71 | < 0.05 |
3주 후 | 17.2 ±5.36 | 12.1 ±6.30 | < 0.05 |
Claims (5)
- 보툴리눔 독소 및 제약상 허용되는 담체를 포함하는, 복재신경 포착에 의한 무릎 관절 통증 치료를 위한, 무릎 내측 위의 피하 주사용 제약 조성물.
- 제1항에 있어서, 약 20 내지 200 LD50 유닛의 상기 보툴리눔 독소를 포함하는 제약 조성물.
- 제1항에 있어서, 상기 제약 조성물이 무릎 내측 위의 복재신경 지배 부위의 과민 수용체가 밀집되어 있는 피하근막에 주사되는 것인 제약 조성물.
- 제1항에 있어서, 상기 보툴리눔 독소가 보툴리눔 독소 타입 A인 제약 조성물.
- 제1항에 있어서, 무릎 관절 통증이 4주 이상 지속적으로 완화되는 것인 제약 조성물.
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040048889A KR100668570B1 (ko) | 2004-06-28 | 2004-06-28 | 복재신경 포착에 의한 무릎 관절 통증 치료를 위한,보툴리눔 독소를 포함하는 제약 조성물 |
PT57658395T PT1771195T (pt) | 2004-06-28 | 2005-06-27 | Composição farmacêutica compreendendo toxina botulínica para tratar dor de articulação de joelho por compressão do nervo safeno |
ES05765839.5T ES2625128T3 (es) | 2004-06-28 | 2005-06-27 | Composición farmacéutica que comprende toxina botulínica para tratar el dolor articular de rodilla por atrapamiento del nervio safeno |
US11/630,099 US20080199497A1 (en) | 2004-06-28 | 2005-06-27 | Pharmaceutical Composition Comprising Botulinum Toxin for Treating Knee Joint Pain by Saphenous Nerve Entrapment |
HUE05765839A HUE033364T2 (en) | 2004-06-28 | 2005-06-27 | Pharmaceutical preparation containing botulinum toxin for treating knee pain due to pinching of nerve saphenus |
PL05765839T PL1771195T3 (pl) | 2004-06-28 | 2005-06-27 | Kompozycja farmaceutyczna zawierająca toksynę botulinową do leczenia bólu stawu kolanowego powodowanego przez uwięźnięcie nerwu odpiszczelowego |
ARP050102648A AR050673A1 (es) | 2004-06-28 | 2005-06-27 | Composicion farmaceutica compuesta por toxina botulinica para el tratamiento del dolor en la articulacion de la rodilla por compresion del nervio safeno |
CA2571415A CA2571415C (en) | 2004-06-28 | 2005-06-27 | Pharmaceutical composition comprising botulinum toxin for treating knee joint pain by saphenous nerve entrapment |
JP2007519119A JP4933429B2 (ja) | 2004-06-28 | 2005-06-27 | 伏在神経絞扼による膝関節痛の治療のための、ボツリヌス毒素を含む薬学組成物 |
EP05765839.5A EP1771195B1 (en) | 2004-06-28 | 2005-06-27 | Pharmaceutical composition comprising botulinum toxin for treating knee joint pain by saphenous nerve entrapment |
DK05765839.5T DK1771195T3 (en) | 2004-06-28 | 2005-06-27 | PHARMACEUTICAL COMPOSITION COMPREHENSIVE BOTULINUM TOXIN FOR TREATMENT OF KNEE PAIN AS A CONSEQUENCE OF NERVUS SAPHENUS |
PCT/KR2005/002002 WO2006001676A1 (en) | 2004-06-28 | 2005-06-27 | Pharmaceutical composition comprising botulinum toxin for treating knee joint pain by saphenous nerve entrapment |
US12/506,622 US8337862B2 (en) | 2004-06-28 | 2009-07-21 | Method for treating knee joint pain caused by saphenous nerve entrapment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040048889A KR100668570B1 (ko) | 2004-06-28 | 2004-06-28 | 복재신경 포착에 의한 무릎 관절 통증 치료를 위한,보툴리눔 독소를 포함하는 제약 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20060000043A KR20060000043A (ko) | 2006-01-06 |
KR100668570B1 true KR100668570B1 (ko) | 2007-01-16 |
Family
ID=35782045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020040048889A KR100668570B1 (ko) | 2004-06-28 | 2004-06-28 | 복재신경 포착에 의한 무릎 관절 통증 치료를 위한,보툴리눔 독소를 포함하는 제약 조성물 |
Country Status (12)
Country | Link |
---|---|
US (2) | US20080199497A1 (ko) |
EP (1) | EP1771195B1 (ko) |
JP (1) | JP4933429B2 (ko) |
KR (1) | KR100668570B1 (ko) |
AR (1) | AR050673A1 (ko) |
CA (1) | CA2571415C (ko) |
DK (1) | DK1771195T3 (ko) |
ES (1) | ES2625128T3 (ko) |
HU (1) | HUE033364T2 (ko) |
PL (1) | PL1771195T3 (ko) |
PT (1) | PT1771195T (ko) |
WO (1) | WO2006001676A1 (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8722060B2 (en) * | 2012-05-23 | 2014-05-13 | William J. Binder | Method of treating vertigo |
PT2854840T (pt) | 2012-05-30 | 2018-03-02 | Harvard College | Neurotoxina botulínica geneticamente modificada |
WO2016002984A1 (ko) * | 2014-06-30 | 2016-01-07 | (주)메디톡스 | 보툴리눔 독소를 유효성분으로 포함하는 골관절염 치료용 약제학적 조성물 및 그를 이용한 골관절염 치료 방법 |
HUE057258T2 (hu) | 2015-03-26 | 2022-05-28 | Harvard College | Szerkesztett Botulinum neurotoxin |
WO2018039506A1 (en) | 2016-08-24 | 2018-03-01 | President And Fellows Of Harvard College | Engineered botulinum neurotoxin |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6464986B1 (en) | 2000-04-14 | 2002-10-15 | Allegan Sales, Inc. | Method for treating pain by peripheral administration of a neurotoxin |
US6623742B2 (en) * | 2001-09-17 | 2003-09-23 | Allergan, Inc. | Methods for treating fibromyalgia |
CA2369810C (en) * | 2002-01-30 | 2007-08-07 | 1474791 Ontario Limited | Method of treating pain |
US20030224019A1 (en) * | 2002-03-01 | 2003-12-04 | O'brien Christopher | Methods of treating nerve entrapment syndromes |
US7300412B2 (en) * | 2002-05-10 | 2007-11-27 | Hospital For Joint Diseases | Methods for therapeutic treatment of carpal tunnel syndrome |
US20040038874A1 (en) * | 2002-08-22 | 2004-02-26 | Osemwota Omoigui | Method of treatment of persistent pain |
US20060178354A1 (en) * | 2003-02-27 | 2006-08-10 | Lucas John M | Methods and compositions for the treatment of chronic pain using dhea and derivatives thereof |
-
2004
- 2004-06-28 KR KR1020040048889A patent/KR100668570B1/ko active IP Right Grant
-
2005
- 2005-06-27 PL PL05765839T patent/PL1771195T3/pl unknown
- 2005-06-27 ES ES05765839.5T patent/ES2625128T3/es active Active
- 2005-06-27 JP JP2007519119A patent/JP4933429B2/ja not_active Expired - Fee Related
- 2005-06-27 PT PT57658395T patent/PT1771195T/pt unknown
- 2005-06-27 DK DK05765839.5T patent/DK1771195T3/en active
- 2005-06-27 CA CA2571415A patent/CA2571415C/en not_active Expired - Fee Related
- 2005-06-27 AR ARP050102648A patent/AR050673A1/es not_active Application Discontinuation
- 2005-06-27 US US11/630,099 patent/US20080199497A1/en not_active Abandoned
- 2005-06-27 WO PCT/KR2005/002002 patent/WO2006001676A1/en active Application Filing
- 2005-06-27 EP EP05765839.5A patent/EP1771195B1/en not_active Not-in-force
- 2005-06-27 HU HUE05765839A patent/HUE033364T2/en unknown
-
2009
- 2009-07-21 US US12/506,622 patent/US8337862B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
ES2625128T3 (es) | 2017-07-18 |
PL1771195T3 (pl) | 2017-08-31 |
JP2008504364A (ja) | 2008-02-14 |
EP1771195A1 (en) | 2007-04-11 |
EP1771195A4 (en) | 2010-08-18 |
JP4933429B2 (ja) | 2012-05-16 |
KR20060000043A (ko) | 2006-01-06 |
HUE033364T2 (en) | 2017-11-28 |
US8337862B2 (en) | 2012-12-25 |
CA2571415C (en) | 2016-10-04 |
DK1771195T3 (en) | 2017-05-15 |
PT1771195T (pt) | 2017-06-05 |
WO2006001676A1 (en) | 2006-01-05 |
US20090317426A1 (en) | 2009-12-24 |
EP1771195B1 (en) | 2017-03-01 |
CA2571415A1 (en) | 2006-01-05 |
US20080199497A1 (en) | 2008-08-21 |
AR050673A1 (es) | 2006-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3238154B2 (ja) | 過度の発汗を軽減するためのボツリヌス毒素含有医薬組成物 | |
JP2010111703A (ja) | ジストニーを処置するためのa型ボツリヌス毒素に続くb型ボツリヌス毒素の使用 | |
US7910116B2 (en) | Use of a botulinum toxin to improve gastric emptying and/or to treat GERD | |
JP2006512316A (ja) | 消化性潰瘍および胃食道逆流疾患を処置するためのボツリヌス毒素の経口製剤およびその使用 | |
WO2011011513A1 (en) | Inhibition of pathological bone formation | |
US8337862B2 (en) | Method for treating knee joint pain caused by saphenous nerve entrapment | |
JP2022548189A (ja) | ボツリヌス菌a型毒素複合体、製剤、およびその使用方法 | |
JP2008504364A5 (ja) | 伏在神経捕捉による膝関節痛の治療のための、ボツリヌス毒素を含む薬学組成物の使用 | |
RU2734159C1 (ru) | Фармацевтическая композиция для лечения болевого синдрома в стопе, включающая ботулинический токсин и гиалуроновую кислоту, и способ лечения болевого синдрома в стопе с ее использованием | |
AU2005215521A1 (en) | Treatment of abnormalities of the first metatarsophalangeal joint of the foot | |
US7820183B2 (en) | Botulinum toxin in treatment of clubfoot relapse | |
US20180280484A1 (en) | Treatment of raynaud's phenomenon using botulinum toxin type b | |
EP3658177B1 (en) | Tool for dosing botulinum neurotoxin | |
RU2788039C2 (ru) | Лечение спастичности нижних конечностей |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121226 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20131219 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20141231 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20151217 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20161220 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20171219 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20181226 Year of fee payment: 13 |